Immunogenicity of a recombinant envelope domain III protein of dengue virus type-4 with various adjuvants in mice.
about
Dengue E Protein Domain III-Based DNA Immunisation Induces Strong Antibody Responses to All Four Viral SerotypesDengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibodyPCP Consensus Sequences of Flaviviruses: Correlating Variance with Vector Competence and Disease PhenotypeNatural Strain Variation and Antibody Neutralization of Dengue Serotype 3 VirusesA novel single-dose dengue subunit vaccine induces memory immune responsesCross-reactivities between human IgMs and the four serotypes of dengue virus as probed with artificial homodimers of domain-III from the envelope proteins.Direct and indirect interactions in the recognition between a cross-neutralizing antibody and the four serotypes of dengue virus.Physicochemical property consensus sequences for functional analysis, design of multivalent antigens and targeted antivirals.Vaccination with dengue virus-like particles induces humoral and cellular immune responses in mice.Simplifying complex sequence information: a PCP-consensus protein binds antibodies against all four Dengue serotypes.Dengue in India.Immunogenicity of a novel tetravalent vaccine formulation with four recombinant lipidated dengue envelope protein domain IIIs in miceVirus-Like Particles Produced in Pichia Pastoris Induce Protective Immune Responses Against Coxsackievirus A16 in Mice.Induction of neutralizing antibodies against four serotypes of dengue viruses by MixBiEDIII, a tetravalent dengue vaccineDomain III of the envelope protein as a dengue vaccine target.Multi-walled carbon nanotubes functionalized with recombinant Dengue virus 3 envelope proteins induce significant and specific immune responses in mice.Working towards dengue as a vaccine-preventable disease: challenges and opportunities.Evaluation of extracellular subviral particles of dengue virus type 2 and Japanese encephalitis virus produced by Spodoptera frugiperda cells for use as vaccine and diagnostic antigens.Dengue virus type-3 envelope protein domain III; expression and immunogenicity.Immunodominance and functional activities of antibody responses to inactivated West Nile virus and recombinant subunit vaccines in mice.Virus-like particles produced in Saccharomyces cerevisiae elicit protective immunity against Coxsackievirus A16 in mice.Development of a pilot-scale production process and characterization of a recombinant Japanese encephalitis virus envelope domain III protein expressed in Escherichia coli.A method to identify protein antigens of Dermanyssus gallinae for the protection of birds from poultry mites.Recent Developments in Recombinant Protein-Based Dengue Vaccines
P2860
Q27304342-6CC5FB60-C533-4842-B35B-19A2AE847D15Q27489654-1082A13C-70BE-41E6-8CE7-802962CCBE62Q27490925-0F2ABFB9-2641-483C-815A-B4C3C54A59F2Q27491299-87CB4124-5622-42CE-8D14-98BCCD75FB77Q28741828-B0946B79-EB9D-43BE-A830-FDF6C1D5AB60Q34354665-FC57311E-1C70-4D6B-AE0C-E176DED277BBQ34408025-DBD090F7-52E2-4D7E-8EFF-F5BE85196D73Q34548508-3D119C67-4B3B-4474-B327-BCF910041654Q35128995-EA59307F-E1EB-4FFE-B79E-EBEC55BDBB93Q36226190-4221A2B9-67F1-4D0F-9718-C69BDC550C0DQ36436289-8800D35A-FF74-476F-914A-B065F7C680DAQ37137235-FF38883B-0DD2-47AA-A9A9-E7D7F52D1E45Q37282912-9F7E2B4A-A008-4437-BB8D-973043903C68Q37500519-54179E2E-25F1-410A-87FB-3B1F924219C7Q37682895-884DE434-3657-4C59-B6AE-A30A40250064Q37736723-D89D4CFD-FBDE-45F6-8245-75724C689EB3Q38657783-CC9CFAD6-64BA-4261-B3F2-59C8C59AFC74Q39674249-8C12DB2E-ECDB-4EEA-B641-7CB877F7182CQ40168970-6F3F7D23-B9B1-4EBA-A448-4783A1B5D308Q40340971-0D2FF681-A9F4-4401-8A9D-4710EBD81082Q42265420-B35DCE88-DC03-4CF3-8989-40EC344F9DA8Q42980135-16464237-955E-494E-8102-7009076B942BQ50246604-1BB8B9FA-F009-4CDB-98E5-C5CF12F20003Q56960671-3B4626AF-3592-42AD-A65D-55A4CEBCF99B
P2860
Immunogenicity of a recombinant envelope domain III protein of dengue virus type-4 with various adjuvants in mice.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Immunogenicity of a recombinan ...... ith various adjuvants in mice.
@en
type
label
Immunogenicity of a recombinan ...... ith various adjuvants in mice.
@en
prefLabel
Immunogenicity of a recombinan ...... ith various adjuvants in mice.
@en
P2093
P50
P1433
P1476
Immunogenicity of a recombinan ...... ith various adjuvants in mice.
@en
P2093
J Pradeep Babu
P V Lakshmana Rao
Priyabrata Pattnaik
P304
P356
10.1016/J.VACCINE.2008.07.006
P407
P577
2008-07-18T00:00:00Z